Intermedin in paraventricular nucleus attenuates sympathetic activity and blood pressure via nitric oxide in hypertensive rats

Hypertension

Volumn 63, Issue 2, 2014, Pages 330-337

  Zhou, Ye Bo ^a   Sun, Hai Jian ^a   Chen, Dan ^a   Liu, Tong Yan ^a   Han, Ying ^a   Wang, Jue Jin ^a   Tang, Chao Shu ^b   Kang, Yu Ming ^c   Zhu, Guo Qing ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^c XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

hypertension; intermedin protein; rat . nitric oxide . paraventricular hypothalamic nucleus

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE RECEPTOR ANTAGONIST; CALCITONIN GENE RELATED PEPTIDE[8-37]; CALCITONIN RECEPTOR LIKE RECEPTOR; INTERMEDIN; MESSENGER RNA; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; RECEPTOR ACTIVITY MODIFYING PROTEIN 1; RECEPTOR ACTIVITY MODIFYING PROTEIN 2; RECEPTOR ACTIVITY MODIFYING PROTEIN 3;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN DAMAGE; CONTROLLED STUDY; DOWN REGULATION; DOWNSTREAM PROCESSING; GENE EXPRESSION; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; KIDNEY SURGERY; LATERAL BRAIN VENTRICLE; MALE; MEAN ARTERIAL PRESSURE; MICROINJECTION; NERVE CONDUCTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RENOVASCULAR HYPERTENSION; SHAM PROCEDURE; SOLITARY TRACT NUCLEUS; SYMPATHETIC NERVE; SYMPATHETIC TONE;

EID: 84892948187     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.113.01681     Document Type: Article

References (36)

1. Roh J, Chang CL, Bhalla A, Klein C, Hsu SY. Intermedin is a calcitonin/calcitonin gene-related peptide family peptide acting through the calcitonin receptor-like receptor/receptor activity-modifying protein receptor complexes. J Biol Chem. 2004;279:7264-7274.
2. Takahashi K, Morimoto R, Hirose T, Satoh F, Totsune K. Adrenomedullin 2/intermedin in the hypothalamo-pituitary-adrenal axis. J Mol Neurosci. 2011;43:182-192.
3. Hong Y, Hay DL, Quirion R, Poyner DR. The pharmacology of adrenomedullin 2/intermedin. Br J Pharmacol. 2012;166:110-120.
4. Takahashi K, Kikuchi K, Maruyama Y, Urabe T, Nakajima K, Sasano H, Imai Y, Murakami O, Totsune K. Immunocytochemical localization of adrenomedullin 2/intermedin-like immunoreactivity in human hypothalamus, heart and kidney. Peptides. 2006;27:1383-1389.
5. Oliver KR, Kane SA, Salvatore CA, Mallee JJ, Kinsey AM, Koblan KS, Keyvan-Fouladi N, Heavens RP, Wainwright A, Jacobson M, Dickerson IM, Hill RG. Cloning, characterization and central nervous system distribution of receptor activity modifying proteins in the rat. Eur J Neurosci. 2001;14:618-628.
6. Stachniak TJ, Krukoff TL. Receptor activity modifying protein 2 distribution in the rat central nervous system and regulation by changes in blood pressure. J Neuroendocrinol. 2003;15:840-850.
7. Hashimoto H, Kitamura K, Kawasaki M, Saito T, Suzuki H, Otsubo H, Ohbuchi T, Yokoyama T, Fujihara H, Takei Y, Ueta Y. Adrenomedullin 2/intermedin-like immunoreactivity in the hypothalamus and brainstem of rats. Auton Neurosci. 2008;139:46-54.
8. Burmeister MA, Young CN, Braga VA, Butler SD, Sharma RV, Davisson RL. In vivo bioluminescence imaging reveals redox-regulated activator protein-1 activation in paraventricular nucleus of mice with renovascular hypertension. Hypertension. 2011;57:289-297.
9. Han Y, Fan ZD, Yuan N, Xie GQ, Gao J, De W, Gao XY, Zhu GQ. Superoxide anions in the paraventricular nucleus mediate the enhanced cardiac sympathetic afferent reflex and sympathetic activity in renovascular hypertensive rats. J Appl Physiol (1985). 2011;110:646-652.
10. Taylor MM, Bagley SL, Samson WK. Intermedin/adrenomedullin-2 acts within central nervous system to elevate blood pressure and inhibit food and water intake. Am J Physiol Regul Integr Comp Physiol. 2005;288:R919-R927.
11. Li P, Sun HJ, Han Y, Wang JJ, Zhang F, Tang CS, Zhou YB. Intermedin enhances sympathetic outflow via receptor-mediated cAMP/PKA signaling pathway in nucleus tractus solitarii of rats. Peptides. 2013;47:1-6.
12. Martins-Pinge MC, Mueller PJ, Foley CM, Heesch CM, Hasser EM. Regulation of arterial pressure by the paraventricular nucleus in conscious rats: interactions among glutamate, GABA, and nitric oxide. Front Physiol. 2012;3:490.
13. Northcott CA, Billecke S, Craig T, Hinojosa-Laborde C, Patel KP, Chen AF, D'Alecy LG, Haywood JR. Nitric oxide synthase, ADMA, SDMA, and nitric oxide activity in the paraventricular nucleus throughout the etiology of renal wrap hypertension. Am J Physiol Heart Circ Physiol. 2012;302:H2276-H2284.
14. Yang JH, Pan CS, Jia YX, Zhang J, Zhao J, Pang YZ, Yang J, Tang CS, Qi YF. Intermedin1-53 activates L-arginine/nitric oxide synthase/nitric oxide pathway in rat aortas. Biochem Biophys Res Commun. 2006;341:567-572.
15. Jolly L, March JE, Kemp PA, Bennett T, Gardiner SM. Mechanisms involved in the regional haemodynamic effects of intermedin (adrenomedullin 2) compared with adrenomedullin in conscious rats. Br J Pharmacol. 2009;157:1502-1513.
16. Li P, Sun HJ, Cui BP, Zhou YB, Han Y. Angiotensin-(1-7) in the rostral ventrolateral medulla modulates enhanced cardiac sympathetic afferent reflex and sympathetic activation in renovascular hypertensive rats. Hypertension. 2013;61:820-827.
17. Zhu GQ, Xu Y, Zhou LM, Li YH, Fan LM, Wang W, Gao XY, Chen Q. Enhanced cardiac sympathetic afferent reflex involved in sympathetic overactivity in renovascular hypertensive rats. Exp Physiol. 2009;94:785-794.
18. Xiong XQ, Chen WW, Han Y, Zhou YB, Zhang F, Gao XY, Zhu GQ. Enhanced adipose afferent reflex contributes to sympathetic activation in diet-induced obesity hypertension. Hypertension. 2012;60:1280-1286.
19. Zhou YB, Gao Q, Li P, Han Y, Zhang F, Qi YF, Tang CS, Gao XY, Zhu GQ. Adrenomedullin attenuates vascular calcification in fructose-induced insulin resistance rats. Acta Physiol (Oxf). 2013;207:437-446.
20. Biaggioni I. Interventional approaches to reduce sympathetic activity in resistant hypertension: to ablate or stimulate? Hypertension. 2012;59:194-195.
21. Brinkmann J, Heusser K, Schmidt BM, Menne J, Klein G, Bauersachs J, Haller H, Sweep FC, Diedrich A, Jordan J, Tank J. Catheter-based renal nerve ablation and centrally generated sympathetic activity in difficultto-control hypertensive patients: prospective case series. Hypertension. 2012;60:1485-1490.
22. Raheja P, Price A, Wang Z, Arbique D, Adams-Huet B, Auchus RJ, Vongpatanasin W. Spironolactone prevents chlorthalidone-induced sympathetic activation and insulin resistance in hypertensive patients. Hypertension. 2012;60:319-325.
23. Mahfoud F, Cremers B, Janker J, et al. Renal hemodynamics and renal function after catheter-based renal sympathetic denervation in patients with resistant hypertension. Hypertension. 2012;60:419-424.
24. Pathan SA, Iqbal Z, Zaidi SM, Talegaonkar S, Vohra D, Jain GK, Azeem A, Jain N, Lalani JR, Khar RK, Ahmad FJ. CNS drug delivery systems: novel approaches. Recent Pat Drug Deliv Formul. 2009;3:71-89.
25. Sun HJ, Li P, Chen WW, Xiong XQ, Han Y. Angiotensin II and angiotensin-( 1-7) in paraventricular nucleus modulate cardiac sympathetic afferent reflex in renovascular hypertensive rats. PLoS One. 2012;7:e52557.
26. Yang JH, Cai Y, Duan XH, Ma CG, Wang X, Tang CS, Qi YF. Intermedin 1-53 inhibits rat cardiac fibroblast activation induced by angiotensin II. Regul Pept. 2009;158:19-25.
27. Li YF, Wang W, Mayhan WG, Patel KP. Angiotensin-mediated increase in renal sympathetic nerve discharge within the PVN: role of nitric oxide. Am J Physiol Regul Integr Comp Physiol. 2006;290:R1035-R1043.
28. Li Y, Zhang W, Stern JE. Nitric oxide inhibits the firing activity of hypothalamic paraventricular neurons that innervate the medulla oblongata: role of GABA. Neuroscience. 2003;118:585-601.
29. Zheng H, Liu X, Li Y, Sharma NM, Patel KP. Gene transfer of neuronal nitric oxide synthase to the paraventricular nucleus reduces the enhanced glutamatergic tone in rats with chronic heart failure. Hypertension. 2011;58:966-973.
30. Xu Y, Krukoff TL. Decrease in arterial pressure induced by adrenomedullin in the hypothalamic paraventricular nucleus is mediated by nitric oxide and GABA. Regul Pept. 2004;119:21-30.
31. Hasegawa T, Yokotani K, Okuma Y, Manabe M, Hirakawa M, Osumi Y. Microinjection of alpha-calcitonin gene-related peptide into the hypothalamus activates sympathetic outflow in rats. Jpn J Pharmacol. 1993;61:325-332.
32. Affleck VS, Coote JH, Pyner S. The projection and synaptic organisation of NTS afferent connections with presympathetic neurons, GABA and nNOS neurons in the paraventricular nucleus of the hypothalamus. Neuroscience. 2012;219:48-61.
33. Averill DB, Diz DI. Angiotensin peptides and baroreflex control of sympathetic outflow: pathways and mechanisms of the medulla oblongata. Brain Res Bull. 2000;51:119-128.
34. Metzner W, Juranek J. A method to biotinylate and histochemically visualize ibotenic acid for pharmacological inactivation studies. J Neurosci Methods. 1997;76:143-150.
35. Zhong MK, Duan YC, Chen AD, Xu B, Gao XY, De W, Zhu GQ. Paraventricular nucleus is involved in the central pathway of cardiac sympathetic afferent reflex in rats. Exp Physiol. 2008;93:746-753.
36. Shi Z, Chen WW, Xiong XQ, Han Y, Zhou YB, Zhang F, Gao XY, Zhu GQ. Sympathetic activation by chemical stimulation of white adipose tissues in rats. J Appl Physiol. 2012;112:1008-1014.